17-Mar-2021

Prostate Cancer Therapeutics Market to Inspire a Growth up to US$ 15.5 Billion by 2025 – Coherent Market Insights

SEATTLE, March 17, 2021, (PHARMIWEB) — Global Prostate Cancer Therapeutics Market

Prostate cancer is caused by the uncontrolled growth of the cells in the prostate gland. Prostate cancer is the most common cancer in men in the U.S., after skin cancer. According to the American Community Survey, 2016, in U.S. prostate cancer is the second leading cause of death among the cancer deaths in men. Almost all prostate cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). Other types of prostate cancer are rare; these include: Sarcomas, small cell carcinomas, neuroendocrine tumors and transitional cell carcinomas. Advanced stage of prostate cancer can cause men to urinate more often or have a weaker flow of urine, but these symptoms can also be caused by benign prostate conditions. In 2017, the American Cancer Society estimated around 161,360 new diagnoses of prostate cancer in the U.S., leading to around 26,730 fatalities. As the cause of the cancer is not known, there is no definite way to prevent prostate cancer. The American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN) recommends that all men over age 40 should have an annual rectal examination and that men have an annual prostate-specific antigen (PSA) test beginning at age of 50 years.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/1257

Rising implications associated with prostate cancer expected to favor the global prostate cancer therapeutics market growth

The global prostate cancer therapeutics market was valued at US$ 8,191.11 million in 2016 and is expected to witness a CAGR of 7.5% during the forecast period (2017 – 2025).

Prostate cancer incidence is strongly associated with age, with the highest incidence rate being among older men. According to the National Cancer Registry Ireland, 2011, median age at prostate cancer diagnosis in Ireland was 67 years with 38.9% of cases being diagnosed in men and 21.3% in men above the age of 75 years. Median age at death was 80 with 70.3% of deaths occurring in men 75+ years. Moreover, several supportive initiatives undertaken by key players in collaboration with various governments to create more awareness of clinical symptoms about prostate cancer and availability of screenings and diagnostic tests, such as Prostate-Specific Antigen (PSA) and Digital Rectal Exam (DRE) resulting in early detection, are the other significant factors expected to boost the global prostate cancer therapeutics market expansion. However, high costs of drugs, and poor reimbursement of treatment costs may affect the global market growth negatively.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://bit.ly/3cVCZKj

Global endeavors to introduce highly effective therapies for prostate cancer to support market growth

The key players operating in the global prostate cancer therapeutics market include Johnson & Johnson, Astella, Inc., Sanofi-Aventis, Bayer AG, AstraZeneca Plc, Pfizer Inc., Dendreon Corporation (Sanpower Group Co. Ltd.), Ipsen Group, Tolmar Inc., Endo Pharmaceuticals, and AbbVie, Inc.

Many research organizations and universities have been investing in research for the development of therapeutic products for the treatment of such tumors. For instance, some pipeline products which are in phase 2 studies, such as Avelumab (Duke University Medical Center), Metformin (Mansoura University), LY2452473 (Dana-Farber Cancer Institute) are expected to arrive in the market in the near future. Furthermore, many products that are about to face patent expiry during the forecast period will also contribute in the growth of the generic prostate cancer therapeutics market. Furthermore, several pharmaceutical companies are concentrating on introducing their respective drugs in different countries to boost the sales of their products. For instance, in December, 2016, Sanofi’s prostate cancer drug name Jevtana (cabazitaxel) for the treatment of metastatic hormone-refractory prostate cancer (mHRPC) was approved by Scottish Medicines Consortium (SMC) for restricted use within NHS Scotland, due to which Scotland’s government has now collaborated with various health authorities in Northern Ireland, England and Wales in order to curb the potential disparities in healthcare across the U.K.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/prostate-cancer-therapeutics-market-to-surge-past-us-155-billion-by-2025-572

Table of Contents

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Regulatory Scenario
- Reimbursement Scenario
- Pipeline Analysis
- PEST Analysis
- PORTER’S Five Forces
Global Prostate Cancer Therapeutics Market, By Drug Type, 2017 – 2025, (US$ Million)
- Introduction
  - Market Share Analysis, 2016 and 2025 (%)
  - Y-o-Y Growth Analysis, 2017 – 2025
  - Segment Trends
- Hormonal Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
        
        Abiraterone Acetate (Zytiga)
        
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
        
        Degarelix Acetate (Firmagon/Gonax)
        
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Luteinizing Hormone-Releasing Hormone (LHRH) Agonist
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
        
        Goserelin Acetate (Zoladex)
        
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
        
        Leuprorelin Acetate (Prostap or Lutrate)
        
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
        
        Triptorelin (Trelstar)
        
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
        
        Others
        
        Introduction
        
        Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Anti-Androgens
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Enzalutamide (Xtandi)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Nilutamide (Nilandron)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Others
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Immunotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Sipuleucel-T (Provenge)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Targeted Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Radium 223 Dichloride (Xofigo)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Chemotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Cabazitaxel (Jevtana)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
    - Docetaxel (Taxotere)
      - Introduction
      - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
Global Prostate Cancer Therapeutics Market, By Distribution Channel, 2017 – 2025, (US$ Million)
- Introduction
  - Market Share Analysis, 2016 and 2025 (%)
  - Y-o-Y Growth Analysis, 2017 – 2025
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2025, (US$ Million)
Global Prostate Cancer Therapeutics Market, By Region, 2017 – 2025, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2016 and 2025 (%)
  - Y-o-Y Growth Analysis, By Region, 2017 – 2025
- North America
  - Market Size and Forecast, By Drug Type, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
    - U.S.
- - - Canada
- Europe
  - Market Size and Forecast, By Drug Type, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Drug Type, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Size and Forecast, By Drug Type, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
    - Brazil
    - Mexico
    - Rest of Latin America
- Africa
  - Market Size and Forecast, By Drug Type, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
    - Northern Africa
    - Central Africa
    - South Africa
- Middle East
  - Market Size and Forecast, By Drug Type, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
  - Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
    - GCC Countries
    - Israel
    - Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Company Profiles
Section
- Analyst Views
- Research Methodology
- About Us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

Company:
- CDN Newswire

Last Updated: 17-Mar-2021